{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:21:27Z","timestamp":1780489287384,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>HIV infection exacerbates the prognosis of HCV infection, with a faster progression of hepatitis. Hepatic fibrosis is the major disruption of the hepatic tissue architecture characterized by anarchic deposition and excess of the extracellular matrix. The objective of this study was to evaluate hepatic fibrosis in HIV\/HCV co-infected individuals as compared to HCV mono-infected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 97 participants (mean age 60.2\u2009\u00b1\u200914.3\u2009years and 0.76 male\/female sex ratio) was enrolled in a study conducted in Yaound\u00e9, Cameroon from November 2018 to January 2019. Liver fibrosis was assessed by the APRI score (Aspartate Aminotransferase or AST\/Platelet Ratio Index) which identifies the stage of fibrosis as classified by the Metavir system (F0 to F4). CD4 counts and plasmatic HIV viral load of HIV\/HCV co-infected individuals were determined and the correlation between hepatic fibrosis and immuno-virological status established. Statistical analysis was done using Microsoft Excel 2016 and EpiInfo7 software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A high proportion (63.6%) of HIV\/HCV co-infected participants had an abnormal AST level: 73.6\u2009\u00b1\u200945.8\u2009IU\/L as compared to 58.5\u2009\u00b1\u200939.3\u2009IU\/L (59.3%) among HCV mono-infected participants. The frequency of thrombocytopenia was 63.6% with a mean platelet count of 137\u2009\u00b1\u200950\u2009\u00d7\u2009\u00a010\n                      <jats:sup>3<\/jats:sup>\n                      IU\/L in HIV\/HCV co-infected participants as compared to 176\u2009\u00b1\u200967\u2009\u00d7\u200910\n                      <jats:sup>3<\/jats:sup>\n                      IU\/L in HCV mono-infected participants (38.4%). The progression of hepatic fibrosis in participants with clinically significant fibrosis: F2, F3 and F4 was higher among HIV\/HCV co-infected and the mean APRI score was 1.7\u2009\u00b1\u20091.4 versus 1\u2009\u00b1\u20090.8 among HCV mono-infected (26.7%). All participants (100%) with detectable HIV viral load had clinically significant fibrosis compared to 33.4% in those with undetectable HIV viral load (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.55). Only 42.9% participants with CD4\u2009&gt;\u2009\u00a0500 cells\/\u03bcL had clinically significant fibrosis (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.72) while 100% participants with CD4\u2009&lt;\u2009\u00a0200 cells\/\u03bcL had clinically significant fibrosis (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.58).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A high level of AST combined with thrombocytopenia (APRI score\u2009&gt;\u20091.5) is an indicator of hepatic fibrosis in HIV\/HCV co-infected individuals. Because of its non-invasive and less costly nature, the APRI score can be a suitable biomarker to monitor hepatic fibrosis in HIV\/HCV co-infected individuals in resource constrained settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05477-7","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T05:02:47Z","timestamp":1602738167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of hepatic fibrosis in HIV\/HCV co-infected individuals in Yaound\u00e9, Cameroon: usefulness of APRI score in resource-constrained settings"],"prefix":"10.1186","volume":"20","author":[{"given":"Rodolphe","family":"Dobseu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2896-0508","authenticated-orcid":false,"given":"Aubin","family":"Nanfack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathurin","family":"Kowo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Ambada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Kamgaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collins","family":"Chenwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Fainguem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Ka\u2019e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Ngangoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Sosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clerg\u00e9","family":"Tchiegang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Ndjolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"5477_CR1","volume-title":"2019 Global HIV Statistics","author":"UNAIDS","year":"2020","unstructured":"UNAIDS. 2019 Global HIV Statistics. 2020. https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"5477_CR2","volume-title":"Infection par le VIH\/Sida et tropiques. Mise \u00e0 jour le 08\/07\/2018","author":"PP Aubry","year":"2018","unstructured":"Aubry PP, Ga\u00fcz\u00e8re B. Infection par le VIH\/Sida et tropiques. Mise \u00e0 jour le 08\/07\/2018 2018; Source: www.medecinetropicale.com ."},{"key":"5477_CR3","volume-title":"Mondiale de la Sante Rapport mondiale sur l'hepatite, 2017","author":"Organisation","year":"2018","unstructured":"Organisation. Mondiale de la Sante Rapport mondiale sur l'hepatite, 2017. 2018. http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/. Accessed 6 Dec 2017."},{"issue":"2","key":"5477_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","volume":"17","author":"D Lavanchy","year":"2011","unstructured":"Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17(2):107\u201315 Epub 2010\/11\/26.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"5477_CR5","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","volume":"16","author":"L Platt","year":"2016","unstructured":"Platt L, Easterbrook P, Gower E, McDonald B, Sabin K, McGowan C, et al. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):797\u2013808 Epub 2016\/02\/29.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"5477_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137375","volume":"10","author":"JJ Noubiap","year":"2015","unstructured":"Noubiap JJ, Aka PV, Nanfack AJ, Agyingi LA, Ngai JN, Nyambi PN. Hepatitis B and C co-infections in some HIV-positive populations in Cameroon, west Central Africa: analysis of samples collected over more than a decade. PLoS One. 2015;10(9):e0137375 Epub 2015\/09\/16.","journal-title":"PLoS One"},{"issue":"1 Suppl","key":"5477_CR7","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.jhep.2005.11.008","volume":"44","author":"A Vallet-Pichard","year":"2006","unstructured":"Vallet-Pichard A, Pol S. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection. J Hepatol. 2006;44(1 Suppl):S28\u201334 Epub 2005\/12\/14.","journal-title":"J Hepatol"},{"key":"5477_CR8","volume-title":"Bulletin_epidemiologique_vih_ndeg5.pdf. 2018","author":"CNLS","year":"2018","unstructured":"CNLS. Bulletin_epidemiologique_vih_ndeg5.pdf. 2018. 2018. Disponible sur: http:\/\/www.cnls.cm\/sites\/default\/files\/bulletin_epidemiologique_vih_ndeg5.pdf."},{"issue":"6","key":"5477_CR9","doi-asserted-by":"publisher","first-page":"9184","DOI":"10.3390\/ijms15069184","volume":"15","author":"CM Mastroianni","year":"2014","unstructured":"Mastroianni CM, Lichtner M, Mascia C, Zuccala P, Vullo V. Molecular mechanisms of liver fibrosis in HIV\/HCV coinfection. Int J Mol Sci. 2014;15(6):9184\u2013208 Epub 2014\/05\/29.","journal-title":"Int J Mol Sci"},{"key":"5477_CR10","volume-title":"Analyse g\u00e9nomique de la coinfection par le virus VIH et VHC (th\u00e8se de doctorat)","author":"D. U","year":"2016","unstructured":"D. U. Analyse g\u00e9nomique de la coinfection par le virus VIH et VHC (th\u00e8se de doctorat). Paris, FRANCE: CNAM; 2016."},{"issue":"2","key":"5477_CR11","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518\u201326 Epub 2003\/07\/29.","journal-title":"Hepatology."},{"issue":"2","key":"5477_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24(2):289\u201393 Epub 1996\/08\/01.","journal-title":"Hepatology"},{"issue":"31","key":"5477_CR13","doi-asserted-by":"publisher","first-page":"7661","DOI":"10.1021\/bi00245a001","volume":"30","author":"TW Myers","year":"1991","unstructured":"Myers TW, Gelfand DH. Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase. Biochemistry. 1991;30(31):7661\u20136 Epub 1991\/08\/06.","journal-title":"Biochemistry."},{"key":"5477_CR14","doi-asserted-by":"crossref","unstructured":"Gonzalez FA, Van den Eynde E, Perez-Hoyos S, Navarro J, Curran A, Burgos J, et al. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus\/HIV-coinfected patients. HIV Med. 2014;16(4):211\u20138 2014.","DOI":"10.1111\/hiv.12197"},{"issue":"4","key":"5477_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/hiv.12105","volume":"15","author":"R Sanmartin","year":"2014","unstructured":"Sanmartin R, Tor J, Sanvisens A, Lopez JJ, Jou A, Muga R, et al. Progression of liver fibrosis in HIV\/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline. HIV Med. 2014;15(4):203\u201312 Epub 2013\/11\/20.","journal-title":"HIV Med"},{"issue":"2","key":"5477_CR16","first-page":"110","volume":"39","author":"M Merli","year":"2016","unstructured":"Merli M, Galli L, Castagna A, Salpietro S, Gianotti N, Messina E, et al. Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV\/HCV-coinfected patients. New Microbiol. 2016;39(2):110\u20133. 2016.","journal-title":"New Microbiol"},{"issue":"4","key":"5477_CR17","first-page":"220","volume":"5","author":"ESM Oksenhendler","year":"1989","unstructured":"Oksenhendler ESM. Thrombop\u00e9nie immunologique associ\u00e9e \u00e0 l\u2019infection HIV. M\u00e9d Sci. 1989;5(4):220 1989.","journal-title":"M\u00e9d Sci"},{"issue":"1","key":"5477_CR18","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1186\/s13104-019-4664-7","volume":"12","author":"AD Nka","year":"2019","unstructured":"Nka AD, Sosso SM, Fokam J, Bouba Y, Teto G, Simo Rachel R, et al. Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaounde. BMC Res Notes. 2019;12(1):632 Epub 2019\/09\/27.","journal-title":"BMC Res Notes"},{"issue":"4","key":"5477_CR19","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/hep.510300409","volume":"30","author":"Y Benhamou","year":"1999","unstructured":"Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology. 1999;30(4):1054\u20138 Epub 1999\/09\/25.","journal-title":"Hepatology"},{"issue":"1","key":"5477_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12879-020-05069-5","volume":"20","author":"E Yunihastuti","year":"2020","unstructured":"Yunihastuti E, Wicaksana B, Wiraguna A, Hidayah AJ, Amelia F, Natali V, et al. Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV\/HCV co-infected patients. BMC Infect Dis. 2020;20(1):372 Epub 2020\/05\/27.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"5477_CR21","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/hep.26115","volume":"57","author":"Z Tian","year":"2013","unstructured":"Tian Z, Chen Y, Gao B. Natural killer cells in liver disease. Hepatology. 2013;57(4):1654\u201362 Epub 2012\/11\/01.","journal-title":"Hepatology."},{"key":"5477_CR22","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3389\/fimmu.2020.01142","volume":"11","author":"M Zhang","year":"2020","unstructured":"Zhang M, Zhang S. T cells in fibrosis and fibrotic diseases. Front Immunol. 2020;11:1142 Epub 2020\/07\/18.","journal-title":"Front Immunol"},{"issue":"5","key":"5477_CR23","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S0168-8278(00)00097-0","volume":"34","author":"T Poynard","year":"2001","unstructured":"Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. J Hepatol. 2001;34(5):730\u20139 Epub 2001\/07\/04.","journal-title":"J Hepatol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05477-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05477-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05477-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T10:05:07Z","timestamp":1634292307000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05477-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5477"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05477-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-44092\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-44092\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-44092\/v3","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]},"assertion":[{"value":"15 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for the current study was obtained from the Cameroon National Research Ethics Board for Human Health. Participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that, this study is without conflicts of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"758"}}